Use of 177Lut-PSMA in metastatic castrate-resistant prostate cancer in the post-chemotherapy setting: Early vs late treatment.

Authors: Eman Ahmed, Milad Bonakdarhashemi, Mohamed E. Ahmed, Kelly Lehner, Jack Andrews, Eugene D. Kwon

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17168

Source: Full article

---

Abstract

e17168